SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-048201
Filing Date
2024-02-28
Accepted
2024-02-27 18:10:48
Documents
11
Effectiveness Date
2024-02-28

Document Format Files

Seq Description Document Type Size
1 S-3ASR d616863ds3asr.htm S-3ASR 412046
2 EX-1.2 d616863dex12.htm EX-1.2 219153
3 EX-4.3 d616863dex43.htm EX-4.3 339803
4 EX-4.4 d616863dex44.htm EX-4.4 340495
5 EX-4.5 d616863dex45.htm EX-4.5 38846
6 EX-4.6 d616863dex46.htm EX-4.6 39279
7 EX-5.1 d616863dex51.htm EX-5.1 28949
8 EX-23.1 d616863dex231.htm EX-23.1 1652
9 EX-FILING FEES d616863dexfilingfees.htm EX-FILING FEES 49916
10 GRAPHIC g616863g39g39.jpg GRAPHIC 32009
11 GRAPHIC g616863g59g59.jpg GRAPHIC 37284
  Complete submission text file 0001193125-24-048201.txt   1559103
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277427 | Film No.: 24689032
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)